Strong Market Presence BioSerenity operates in a growing sector of connected medical devices for chronic disease monitoring, serving over 200 hospitals across Europe and diagnosing more than 100,000 patients annually, indicating a substantial adoption of digital health solutions.

Recent Funding Momentum The company secured significant investments of approximately 26 million euros, with notable investments from private equity firms and major industry players like Dassault Systèmes, highlighting strong investor confidence and growth potential.

Strategic Partnerships BioSerenity has formed key collaborations with neurodiagnostic leaders such as Stratus Neuro and APRIL International, opening avenues for joint sales, distribution, and expanding their reach into specialized markets like neurology and cardiology.

Innovative Technology Stack Leveraging advanced IoT platforms, AI, textile sensors, and digital biomarkers, BioSerenity's solutions appeal to healthcare providers seeking next-generation, integrated diagnostic tools for chronic disease management.

Growth and Expansion Opportunities With robust funding rounds and ongoing product development in wearable and point-of-care solutions, there are significant opportunities to introduce complementary medical devices, telehealth services, and expanded clinical partnerships to enhance market penetration.